Despite worries that COVID-19 symptoms can return after patients take the drug Paxlovid, such cases of rebound symptoms are actually rare, a new study shows. In an advisory last month, the U.S. Centers for Disease Control and Prevention cautioned that COVID-19 can sometimes make a comeback after an infected person has gone through a round… read on > read on >
Bouncing on a trampoline is always risky, but kids are more likely to suffer serious injuries at a trampoline center than at home, according to researchers who are calling for mandatory safety standards at the centers. U.S. emergency departments treat nearly 100,000 children a year for trampoline injuries. The popularity of trampoline centers has soared… read on > read on >
In yet another sign that the pandemic has exacerbated disparities in health care, researchers report that the life expectancy of Native Americans plummeted by nearly five years as the new coronavirus raged across the country. The loss in longevity was far greater than any other ethnic group and about three times higher than whites. The… read on > read on >
Hot flashes are one of the most well-known symptoms of menopause and they can be severe and frequent, happening throughout the day and night over several years. Researchers say they have found a new, effective treatment that could provide relief and an alternative to existing therapies. “The simple truth is for many years, we did… read on > read on >
Yet another study shows that ivermectin provides no benefits for COVID-19 patients, but researchers say they’ll continue to study a higher dose of the drug. Even though the drug used for parasitic infections in animals and people is not approved by the U.S. Food and Drug Administration to treat COVID-19, some have touted it as… read on > read on >
An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness. A condition of Health Canada’s approval of Albrioza (AMX0035) calls for Massachusetts-based drug maker Amylyx Pharmaceuticals later to provide better evidence… read on > read on >
Called “forever chemicals” because they linger in the environment, new research suggests that middle-aged women with high levels of perfluoroalkyls and polyfluoroalkyls (PFAS) in their blood may be more vulnerable to high blood pressure. In the study, women aged 45 to 56 who had the highest concentrations of seven of these chemicals were 71% more… read on > read on >
MONDAY, June 13, 2022 (American Heart Association News) — Terita Grier has struggled with obesity her whole life. She also has diabetes and high blood pressure, two leading risk factors for heart disease. Her dad died of a massive heart attack a month before she got married in her mid-20s. As she approached 50, Grier… read on > read on >
One American city’s “radical” approach to handling low-level 911 calls — sending mental health professionals rather than police — may have taken a bite out of crime, a new study finds. The study evaluated Denver’s STAR program, which removed police from the response to select 911 calls: those involving a nonviolent person suffering from a… read on > read on >
Antibody levels suggest that three doses of Pfizer’s pediatric COVID vaccine help guard children under 5 against infection, a new analysis from the U.S. Food and Drug Administration shows. It was posted online Sunday ahead of an FDA advisory panel meeting scheduled for Wednesday. On that day, the panel will weigh whether the FDA should… read on > read on >
